We are live on ! Find out more
EP

Elkfork Partners Portfolio holdings

AUM $4.11B
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+5.26%
3 Year Est. Return
+52.4%
5 Year Est. Return
10 Year Est. Return
AUM
$4.21B
AUM Growth
+$323M
Cap. Flow
+$69.3M
Cap. Flow %
1.65%
Top 10 Hldgs %
23.38%
Holding
1,044
New
39
Increased
664
Reduced
239
Closed
30

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$14.9M
2
XOM icon
ExxonMobil
XOM
+$13.7M
3
TDOC icon
Teladoc Health
TDOC
+$13.4M
4
MET icon
MetLife
MET
+$13.3M
5
KNX icon
Knight Transportation
KNX
+$12.7M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$21.3M
2
CAT icon
Caterpillar
CAT
+$18.6M
3
SLB icon
SLB Ltd
SLB
+$16.1M
4
CA
CA, Inc.
CA
+$14.9M
5
MSM icon
MSC Industrial Direct
MSM
+$14.4M

Sector Composition

Rank Sector Weight
1 Technology 18.23%
2 Financials 15.62%
3 Healthcare 14.25%
4 Consumer Discretionary 13.19%
5 Industrials 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLIC icon
801
Kulicke & Soffa
KLIC
$4.67B
$239K 0.01%
10,010
+1,606
+19% +$41.7K
MATW icon
802
Matthews International
MATW
$866M
$239K 0.01%
4,760
+672
+16% +$36.2K
MXL icon
803
MaxLinear
MXL
$6.06B
$239K 0.01%
12,040
+4,928
+69% +$89.7K
SANM icon
804
Sanmina
SANM
$9.95B
$239K 0.01%
8,668
+1,122
+15% +$33.6K
SYNA icon
805
Synaptics
SYNA
$4.19B
$239K 0.01%
5,236
+952
+22% +$45.3K
WERN icon
806
Werner Enterprises
WERN
$2.24B
$239K 0.01%
6,754
+1,540
+30% +$57.1K
TRHC
807
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$239K 0.01%
2,940
+1,456
+98% +$107K
JAZZ icon
808
Jazz Pharmaceuticals
JAZZ
$15.9B
$237K 0.01%
1,408
+1,232
+700% +$212K
ECPG icon
809
Encore Capital Group
ECPG
$2.02B
$236K 0.01%
6,596
+1,360
+26% +$51.5K
LZB icon
810
La-Z-Boy
LZB
$1.58B
$236K 0.01%
7,458
+1,914
+35% +$60.9K
SCL icon
811
Stepan Co
SCL
$1.46B
$236K 0.01%
2,706
+396
+17% +$34.1K
GRFS
812
Grifois
GRFS
$5.36B
$234K 0.01%
10,948
HNI icon
813
HNI Corp
HNI
$3.24B
$234K 0.01%
5,280
+616
+13% +$26K
HF
814
DELISTED
HFF Inc.
HF
$232K 0.01%
5,456
+770
+16% +$32.4K
RCI icon
815
Rogers Communications
RCI
$18.3B
$231K 0.01%
4,536
+2,016
+80% +$103K
TTMI icon
816
TTM Technologies
TTMI
$12B
$231K 0.01%
14,504
+2,912
+25% +$52.1K
MGLN
817
DELISTED
Magellan Health Services, Inc.
MGLN
$230K 0.01%
3,190
+506
+19% +$40.7K
DDS icon
818
Dillards
DDS
$9.19B
$228K 0.01%
2,992
+660
+28% +$53.5K
USPH icon
819
US Physical Therapy
USPH
$1.2B
$227K 0.01%
1,914
+374
+24% +$42.2K
HUBS icon
820
HubSpot
HUBS
$12.2B
$226K 0.01%
1,496
-340
-19% -$46.7K
CUK
821
DELISTED
Carnival PLC
CUK
$225K 0.01%
3,570
FELE icon
822
Franklin Electric
FELE
$4.63B
$225K 0.01%
4,752
+440
+10% +$21.1K
AEG icon
823
Aegon
AEG
$14B
$224K 0.01%
40,603
-1,098
-3% -$5.71K
FORM icon
824
FormFactor
FORM
$8.28B
$219K 0.01%
15,912
+2,720
+21% +$37.5K
ROCK icon
825
Gibraltar Industries
ROCK
$1.25B
$218K 0.01%
4,788
+784
+20% +$33.9K

Similar funds

Elkfork Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Elkfork Partners held 1,044 positions worth $4.21B, up 8.3% from $3.88B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Elkfork Partners's Q3 2018 filing shows 39 new, 664 increased, 239 reduced and 30 closed positions. Its largest new stake was VICI Properties: 120,876 shares worth $2.61M. The largest sale was Gilead Sciences, an estimated $21.3M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Elkfork Partners's largest Q3 2018 buy was VICI Properties: 120,876 shares worth $2.61M.
  • Elkfork Partners added most to Salesforce in Q3 2018, an estimated $14.9M increase.
  • Elkfork Partners's biggest Q3 2018 reduction was Gilead Sciences, cutting an estimated $21.3M.
  • Elkfork Partners fully exited Energen in Q3 2018, selling an estimated $3.57M.
  • Elkfork Partners's ten largest holdings make up 23% of its $4.21B portfolio in Q3 2018.
  • Elkfork Partners opened 39 new positions and closed 30 in Q3 2018.
  • Elkfork Partners's portfolio value rose 8.3% quarter-over-quarter to $4.21B.

Based on Elkfork Partners's 13F filing for Q3 2018, filed 14 Nov 2018.